Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Phenotypes of organ involvement in sarcoidosis.

Schupp JC, Freitag-Wolf S, Bargagli E, Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O'Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, O'Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J.

Eur Respir J. 2018 Jan 25;51(1). pii: 1700991. doi: 10.1183/13993003.00991-2017. Print 2018 Jan.

2.

Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.

Collard HR, Richeldi L, Kim DS, Taniguchi H, Tschoepe I, Luisetti M, Roman J, Tino G, Schlenker-Herceg R, Hallmann C, du Bois RM.

Eur Respir J. 2017 May 19;49(5). pii: 1601339. doi: 10.1183/13993003.01339-2016. Print 2017 May.

3.

Illness denial questionnaire for patients and caregivers.

Rossi Ferrario S, Giorgi I, Baiardi P, Giuntoli L, Balestroni G, Cerutti P, Manera M, Gabanelli P, Solara V, Fornara R, Luisetti M, Omarini P, Omarini G, Vidotto G.

Neuropsychiatr Dis Treat. 2017 Mar 23;13:909-916. doi: 10.2147/NDT.S128622. eCollection 2017.

4.

Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures.

Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F, Grutters J, Nakata K, Van Moorsel CH, Costabel U, Cottin V, Ichiwata T, Inoue Y, Braschi A, Bonizzoni G, Iotti GA, Tinelli C, Rodi G; WLL International Study Group.

Orphanet J Rare Dis. 2016 Aug 31;11(1):115. doi: 10.1186/s13023-016-0497-9.

5.

A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis.

Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F, Grutters JC, Nakata K, Van Moorsel CH, Costabel U, Cottin V, Ichiwata T, Inoue Y, Braschi A, Bonizzoni G, Iotti GA, Tinelli C, Rodi G; WLL International Study Group.

Chest. 2016 Jul;150(1):251-3. doi: 10.1016/j.chest.2016.04.030. No abstract available.

6.

Protein networks in induced sputum from smokers and COPD patients.

Baraniuk JN, Casado B, Pannell LK, McGarvey PB, Boschetto P, Luisetti M, Iadarola P.

Int J Chron Obstruct Pulmon Dis. 2015 Sep 15;10:1957-75. doi: 10.2147/COPD.S75978. eCollection 2015.

7.

How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?

Ferrarotti I, Poplawska-Wisniewska B, Trevisan MT, Koepke J, Dresel M, Koczulla R, Ottaviani S, Baldo R, Gorrini M, Sala G, Cavallon L, Welte T, Chorostowska-Wynimko J, Luisetti M, Janciauskiene S.

PLoS One. 2015 Aug 13;10(8):e0135316. doi: 10.1371/journal.pone.0135316. eCollection 2015.

8.

GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders.

Griese M, Zarbock R, Costabel U, Hildebrandt J, Theegarten D, Albert M, Thiel A, Schams A, Lange J, Krenke K, Wesselak T, Schön C, Kappler M, Blum H, Krebs S, Jung A, Kröner C, Klein C, Campo I, Luisetti M, Bonella F.

BMC Pulm Med. 2015 Aug 12;15:87. doi: 10.1186/s12890-015-0083-2.

9.

Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis.

Piccoli L, Campo I, Fregni CS, Rodriguez BM, Minola A, Sallusto F, Luisetti M, Corti D, Lanzavecchia A.

Nat Commun. 2015 Jun 16;6:7375. doi: 10.1038/ncomms8375.

10.

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma.

Pignochino Y, Dell'Aglio C, Inghilleri S, Zorzetto M, Basiricò M, Capozzi F, Canta M, Piloni D, Cemmi F, Sangiolo D, Gammaitoni L, Soster M, Marchiò S, Pozzi E, Morbini P, Luisetti M, Aglietta M, Grignani G, Stella GM.

BMC Cancer. 2015 May 8;15:374. doi: 10.1186/s12885-015-1363-1.

11.

Italian registry of patients with alpha-1 antitrypsin deficiency: general data and quality of life evaluation.

Luisetti M, Ferrarotti I, Corda L, Ottaviani S, Gatta N, Tinelli C, Bruletti G, Bertella E, Balestroni G, Confalonieri M, Seebacher C, Iannacci L, Ferrari S, Salerno FG, Mariani F, Carone M, Balbi B.

COPD. 2015 May;12 Suppl 1:52-7. doi: 10.3109/15412555.2015.1023393.

PMID:
25938293
12.

Identification and characterisation of eight novel SERPINA1 Null mutations.

Ferrarotti I, Carroll TP, Ottaviani S, Fra AM, O'Brien G, Molloy K, Corda L, Medicina D, Curran DR, McElvaney NG, Luisetti M.

Orphanet J Rare Dis. 2014 Nov 26;9:172. doi: 10.1186/s13023-014-0172-y.

13.

Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.

Baraldo S, Turato G, Lunardi F, Bazzan E, Schiavon M, Ferrarotti I, Molena B, Cazzuffi R, Damin M, Balestro E, Luisetti M, Rea F, Calabrese F, Cosio MG, Saetta M.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):402-9. doi: 10.1164/rccm.201403-0529OC.

PMID:
25412116
14.

Inherited alpha1-antitrypsin deficiency: is the level the key message?

Ottaviani S, Gorrini M, Ferrarotti I, Luisetti M.

Rev Mal Respir. 2014 Oct;31(8):687-90. doi: 10.1016/j.rmr.2014.06.003. Epub 2014 Sep 23. No abstract available.

PMID:
25391502
15.

The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency.

Pini L, Tiberio L, Venkatesan N, Bezzi M, Corda L, Luisetti M, Ferrarotti I, Malerba M, Lomas DA, Janciauskiene S, Vizzardi E, Modina D, Schiaffonati L, Tantucci C.

Respir Res. 2014 Sep 14;15:112. doi: 10.1186/s12931-014-0112-3.

16.

Activation of oncogenic pathways in idiopathic pulmonary fibrosis.

Stella GM, Inghilleri S, Pignochino Y, Zorzetto M, Oggionni T, Morbini P, Luisetti M.

Transl Oncol. 2014 Oct;7(5):650-5. doi: 10.1016/j.tranon.2014.05.002. Epub 2014 Jun 14.

17.

A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant.

Campo I, Zorzetto M, Mariani F, Kadija Z, Morbini P, Dore R, Kaltenborn E, Frixel S, Zarbock R, Liebisch G, Hegermann J, Wrede C, Griese M, Luisetti M.

Respir Res. 2014 Apr 15;15:43. doi: 10.1186/1465-9921-15-43.

18.

COPD: no gene left unturned.

Ferrarotti I, Luisetti M.

Lancet Respir Med. 2014 Mar;2(3):171-2. doi: 10.1016/S2213-2600(14)70026-8. Epub 2014 Feb 7. No abstract available.

PMID:
24621676
19.

Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004-2013.

Viglio S, Stolk J, Iadarola P, Giuliano S, Luisetti M, Salvini R, Fumagalli M, Bardoni A.

Proteomes. 2014 Jan 22;2(1):18-52. doi: 10.3390/proteomes2010018. Review.

20.

Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics.

Stella GM, Luisetti M, Pozzi E, Comoglio PM.

Lancet Respir Med. 2013 May;1(3):251-61. doi: 10.1016/S2213-2600(13)70009-2. Epub 2013 Mar 1. Review.

PMID:
24429131
21.

From micellar electrokinetic chromatography to liquid chromatography-mass spectrometry: revisiting the way of analyzing human fluids for the search of desmosines, putative biomarkers of chronic obstructive pulmonary disease.

Viglio S, Stolk J, Luisetti M, Ferrari F, Piccinini P, Iadarola P.

Electrophoresis. 2014 Jan;35(1):109-18. doi: 10.1002/elps.201300159. Epub 2013 Oct 23. Review.

PMID:
24395662
22.

Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline.

Mehta AJ, Thun GA, Imboden M, Ferrarotti I, Keidel D, Künzli N, Kromhout H, Miedinger D, Phuleria H, Rochat T, Russi EW, Schindler C, Schwartz J, Vermeulen R, Luisetti M, Probst-Hensch N; SAPALDIA team.

Occup Environ Med. 2014 Apr;71(4):234-40. doi: 10.1136/oemed-2013-101592. Epub 2013 Nov 8.

PMID:
24213563
23.

α₁-Antitrypsin level and pheno/genotypes.

Ferrarotti I, Thun GA, Probst-Hensch NM, Luisetti M.

Chest. 2013 Nov;144(5):1732-1733. doi: 10.1378/chest.13-1464. No abstract available.

PMID:
24189872
24.

The parallel lives of alpha1-antitrypsin deficiency and pulmonary alveolar proteinosis.

Trapnell BC, Luisetti M.

Orphanet J Rare Dis. 2013 Sep 30;8:153. doi: 10.1186/1750-1172-8-153. Review.

25.

Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels.

Thun GA, Imboden M, Ferrarotti I, Kumar A, Obeidat M, Zorzetto M, Haun M, Curjuric I, Couto Alves A, Jackson VE, Albrecht E, Ried JS, Teumer A, Lopez LM, Huffman JE, Enroth S, Bossé Y, Hao K, Timens W, Gyllensten U, Polasek O, Wilson JF, Rudan I, Hayward C, Sandford AJ, Deary IJ, Koch B, Reischl E, Schulz H, Hui J, James AL, Rochat T, Russi EW, Jarvelin MR, Strachan DP, Hall IP, Tobin MD, Dahl M, Fallgaard Nielsen S, Nordestgaard BG, Kronenberg F, Luisetti M, Probst-Hensch NM.

PLoS Genet. 2013;9(8):e1003585. doi: 10.1371/journal.pgen.1003585. Epub 2013 Aug 22.

26.

Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy.

Greulich T, Ottaviani S, Bals R, Lepper PM, Vogelmeier C, Luisetti M, Ferrarotti I.

Respir Med. 2013 Sep;107(9):1400-8. doi: 10.1016/j.rmed.2013.04.023. Epub 2013 Jun 17.

27.

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.

Stella GM, Scabini R, Inghilleri S, Cemmi F, Corso S, Pozzi E, Morbini P, Valentini A, Dore R, Ferrari S, Luisetti M, Zorzetto M.

J Cancer Res Clin Oncol. 2013 Aug;139(8):1327-35. doi: 10.1007/s00432-013-1444-y. Epub 2013 May 5.

PMID:
23644698
28.

Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.

Boschetto P, Campo I, Stendardo M, Casimirri E, Tinelli C, Gorrini M, Ceconi C, Fucili A, Potena A, Papi A, Ballerin L, Fabbri LM, Luisetti M.

Eur J Clin Invest. 2013 Jun;43(6):562-9. doi: 10.1111/eci.12079. Epub 2013 Apr 17.

PMID:
23590548
29.

The role of desmosines as biomarkers for chronic obstructive pulmonary disease.

Iadarola P, Luisetti M.

Expert Rev Respir Med. 2013 Apr;7(2):137-44. doi: 10.1586/ers.13.4. Review.

PMID:
23547990
30.

Assessment and management of pulmonary alveolar proteinosis in a reference center.

Campo I, Mariani F, Rodi G, Paracchini E, Tsana E, Piloni D, Nobili I, Kadija Z, Corsico A, Cerveri I, Chalk C, Trapnell BC, Braschi A, Tinelli C, Luisetti M.

Orphanet J Rare Dis. 2013 Mar 13;8:40. doi: 10.1186/1750-1172-8-40.

31.

The rapid FEV(1) decline in chronic obstructive pulmonary disease is associated with predominant emphysema: a longitudinal study.

Cerveri I, Corsico AG, Grosso A, Albicini F, Ronzoni V, Tripon B, Imberti F, Galasso T, Klersy C, Luisetti M, Pistolesi M.

COPD. 2013 Feb;10(1):55-61. doi: 10.3109/15412555.2012.727920. Epub 2012 Dec 28.

PMID:
23272662
32.

Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency.

Piras B, Ferrarotti I, Lara B, Martinez MT, Bustamante A, Ottaviani S, Pirina P, Luisetti M, Miravitlles M.

Eur Respir J. 2013 Jul;42(1):54-64. doi: 10.1183/09031936.00104712. Epub 2012 Dec 6.

33.

Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.

Fumagalli M, Ferrari F, Luisetti M, Stolk J, Hiemstra PS, Capuano D, Viglio S, Fregonese L, Cerveri I, Corana F, Tinelli C, Iadarola P.

Int J Mol Sci. 2012 Oct 29;13(11):13894-910. doi: 10.3390/ijms131113894.

34.

Micellar electrokinetic chromatography with laser induced detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: a comparative analysis.

Ferrari F, Fumagalli M, Piccinini P, Stolk J, Luisetti M, Viglio S, Tinelli C, Iadarola P.

J Chromatogr A. 2012 Nov 30;1266:103-9. doi: 10.1016/j.chroma.2012.10.014. Epub 2012 Oct 13.

PMID:
23116803
35.

Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges.

Campo I, Kadija Z, Mariani F, Paracchini E, Rodi G, Mojoli F, Braschi A, Luisetti M.

Multidiscip Respir Med. 2012 Jun 11;7(1):4. doi: 10.1186/2049-6958-7-4.

36.

SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort.

Thun GA, Ferrarotti I, Imboden M, Rochat T, Gerbase M, Kronenberg F, Bridevaux PO, Zemp E, Zorzetto M, Ottaviani S, Russi EW, Luisetti M, Probst-Hensch NM.

PLoS One. 2012;7(8):e42728. doi: 10.1371/journal.pone.0042728. Epub 2012 Aug 13.

37.

Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization.

Fra AM, Gooptu B, Ferrarotti I, Miranda E, Scabini R, Ronzoni R, Benini F, Corda L, Medicina D, Luisetti M, Schiaffonati L.

PLoS One. 2012;7(6):e38405. doi: 10.1371/journal.pone.0038405. Epub 2012 Jun 18.

38.

Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency.

Koczulla AR, Jonigk D, Wolf T, Herr C, Noeske S, Klepetko W, Vogelmeier C, von Neuhoff N, Rische J, Wrenger S, Golpon H, Voswinckel R, Luisetti M, Ferrarotti I, Welte T, Janciauskiene S.

Orphanet J Rare Dis. 2012 May 23;7:29. doi: 10.1186/1750-1172-7-29.

39.

Primary lung adenocarcinoma: characteristics by smoking habit and sex.

Stella GM, Luisetti M, Pozzi E.

Eur Respir J. 2012 Apr;39(4):1051-2. doi: 10.1183/09031936.00219811. No abstract available.

40.

Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis.

Luisetti M.

Eur Respir J. 2012 Apr;39(4):1049. doi: 10.1183/09031936.00226311. No abstract available.

41.

Desmosine, a biomarker for COPD: old and in the way.

Luisetti M, Stolk J, Iadarola P.

Eur Respir J. 2012 Apr;39(4):797-8. doi: 10.1183/09031936.00172911. No abstract available.

42.

Serum levels and genotype distribution of α1-antitrypsin in the general population.

Ferrarotti I, Thun GA, Zorzetto M, Ottaviani S, Imboden M, Schindler C, von Eckardstein A, Rohrer L, Rochat T, Russi EW, Probst-Hensch NM, Luisetti M.

Thorax. 2012 Aug;67(8):669-74. doi: 10.1136/thoraxjnl-2011-201321. Epub 2012 Mar 16.

PMID:
22426792
43.

Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe.

Luisetti M, Balfour-Lynn IM, Johnson SR, Miravitlles M, Strange C, Trapnell BC, van Bronswijk H, Vogelmeier C.

Respir Med. 2012 Jun;106(6):759-68. doi: 10.1016/j.rmed.2012.02.016. Epub 2012 Mar 11. Review.

44.

Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance.

Barilli A, Rotoli BM, Visigalli R, Bussolati O, Gazzola GC, Gatti R, Dionisi-Vici C, Martinelli D, Goffredo BM, Font-Llitjós M, Mariani F, Luisetti M, Dall'Asta V.

Mol Genet Metab. 2012 Apr;105(4):585-9. doi: 10.1016/j.ymgme.2012.01.008. Epub 2012 Jan 17.

PMID:
22325938
45.

Targeting EGFR in non-small-cell lung cancer: lessons, experiences, strategies.

Stella GM, Luisetti M, Inghilleri S, Cemmi F, Scabini R, Zorzetto M, Pozzi E.

Respir Med. 2012 Feb;106(2):173-83. doi: 10.1016/j.rmed.2011.10.015. Epub 2011 Nov 21. Review.

46.

Synchronous lung cancers: when same histological types feature different molecular profiles and response phenotypes.

Stella GM, Cemmi F, Inghilleri S, Zorzetto M, Luisetti M, Pozzi E.

J Cancer. 2011;2:474-7. Epub 2011 Sep 23.

47.

Erratum to "factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study".

Inghilleri S, Morbini P, Campo I, Zorzetto M, Oggionni T, Pozzi E, Luisetti M.

Pulm Med. 2011;2011:515608. doi: 10.1155/2011/515608. Epub 2011 Aug 1. No abstract available.

48.

Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis.

Morbini P, Inghilleri S, Campo I, Oggionni T, Zorzetto M, Luisetti M.

Pathol Res Pract. 2011 Sep 15;207(9):559-67. doi: 10.1016/j.prp.2011.06.006. Epub 2011 Jul 27.

PMID:
21798671
49.

Long-term variability of desmosine/isodesmosine as biomarker in alpha-1-antritrypsin deficiency-related COPD.

Fregonese L, Ferrari F, Fumagalli M, Luisetti M, Stolk J, Iadarola P.

COPD. 2011 Oct;8(5):329-33. doi: 10.3109/15412555.2011.589871. Epub 2011 Jul 27.

PMID:
21793711
50.

Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease.

Turino GM, Ma S, Lin YY, Cantor JO, Luisetti M.

Am J Respir Crit Care Med. 2011 Sep 15;184(6):637-41. doi: 10.1164/rccm.201103-0450PP. Review.

PMID:
21757624

Supplemental Content

Loading ...
Support Center